IP Library Patent Application 18399822
Patent Application
App. No. 18/399,822

NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/399,822
Abstract

According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.

Claims (31)

1 - 2 . (canceled)

3 . A method of treating a subject having hypertension, the method comprising:

inserting a radiofrequency (RF) catheter into vasculature of a subject, wherein the RF catheter comprises a distal portion comprising at least one electrode;

intravascularly positioning the at least one electrode of the RF catheter within a portion of a hepatic artery of the vasculature; and

delivering RF energy via the RF catheter to a wall of the hepatic artery sufficient to denervate one or more nerves innervating a liver to treat one or more symptoms associated with hypertension,

wherein the at least one electrode is configured to contact the wall of the hepatic artery while the RF energy is being delivered.

4 . The method of claim 3 , wherein the one or more nerves comprise sympathetic nerves of the hepatic plexus.

5 . The method of claim 3 , wherein a contact pressure of about 0.1 g/mm 2 to about 100 g/mm 2 is exerted on the wall by the distal portion of the RF catheter.

6 . The method of claim 3 , wherein the RF energy delivered by the at least one electrode to the wall is in a range of 100 J to 1 kJ.

7 . The method of claim 6 ,

wherein the RF energy is delivered at a frequency in a range of 50 kHz to 5 MHz, and

wherein the RF energy is delivered to heat the one or more nerves sufficient to cause ablation of the one or more nerves.

8 . The method of claim 3 , further comprising at least partially occluding flow within the hepatic artery.

9 . The method of claim 3 , wherein the at least one electrode comprises a plurality of electrodes spaced along the distal portion of the RF catheter.

10 . The method of claim 3 , wherein delivering RF energy to the wall of the hepatic artery comprises causing energy to be preferentially delivered by the at least one electrode to sympathetic nerves surrounding the hepatic artery.

11 . The method of claim 10 , wherein causing energy to be preferentially delivered by the at least one electrode to sympathetic nerves surrounding the hepatic artery comprises causing the at least one electrode to deliver energy in a proximal portion of the hepatic artery.

12 . The method of claim 11 , wherein the proximal portion of the hepatic artery comprises a common hepatic artery.

13 . The method of claim 3 , wherein the hepatic artery comprises at least one of a common hepatic artery, a proper hepatic artery, a right hepatic artery, or a left hepatic artery.

14 . The method of claim 3 , wherein the hepatic artery comprises a common hepatic artery.

15 . A method of treating a subject having hypertension, the method comprising:

intravascularly delivering a distal portion of a radiofrequency (RF) energy delivery catheter to a vicinity of a liver of a subject;

disrupting neural communication along a sympathetic nerve fiber by causing RF energy to be emitted from one or more electrodes positioned on the distal portion of the RF energy delivery catheter to treat hypertension; and

removing the RF energy delivery catheter from the subject.

16 . The method of claim 15 , wherein the RF energy delivery catheter is delivered intravascularly through a femoral or radial artery to a location within the common hepatic artery.

17 . The method of claim 15 , wherein intravascularly delivering a distal portion of the RF energy delivery catheter to the vicinity of the liver of the subject comprises positioning the one or more electrodes of the RF energy delivery catheter within a portion of the common hepatic artery.

18 . The method of claim 15 , wherein disrupting neural communication along the sympathetic nerve fiber comprises permanent termination of nerve conduction along the sympathetic nerve fiber.

19 . The method of claim 15 , wherein disrupting neural communication along the sympathetic nerve fiber comprises temporarily slowing or terminating nerve conduction along the sympathetic nerve fiber.

20 . The method of claim 15 , wherein disrupting neural communication along the sympathetic nerve fiber comprises disrupting neural communication along a plurality of sympathetic nerve fibers of the hepatic plexus simultaneously.

21 . The method of claim 15 ,

wherein the RF energy is emitted at a frequency in a range of 50 kHz to 5 MHz, and

wherein the RF energy emitted is sufficient to cause ablation of the sympathetic nerve fiber.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2023
From: AZAMIAN, BOBAK ROBERT; COE, JONATHAN ALLEN; VAFAI, SCOTT BRADLEY
To: METAVENTION, INC.
Reel/Frame 065978/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2023
From: METAVENTION, INC.
To: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Reel/Frame 065978/0671 →